Reconstruction of vascular access with vascular graft from autologous dermal fibroblasts

Itoh Manabu0 个研究点目标入组 3 人开始时间: 2019年11月7日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Age >=20
•2. Subjects with vascular access for hemodialysis which is judged to need replacement or bypass of stenosis, or replacement of aneurysm
•3. Judged appropriate for this trial from a result of pre-test
•4. Written informed consent

•1. Subjects with active infection or medical history
•2. Subjects with positive for syphilis, HBs antigen, HCV antibody, HIV gene, HTLV-1 antibody, or parvovirus B19 antibody in pre-test. But, if antibody is positive, judged infectivity
•3. Subject with severe heart failure, or severe liver disorder
•4. Subjects with acute phase myocardial infarction, or cerebral infarction
•5. Subjects with active tumor, or a history of malignant tumor (excluding intraepithelial neoplasia) within 5 years
•6. Subjects with drug dependence, or alcohol dependence
•7. Subjects who participated in other clinical research within 3 months
•8. Subjects who have a history of drug hypersensitivity (including aminoglycosides and polyene antibiotics)
•9. Subjects with allergies to animals (cow) and metals
•10. Subjects with a history of anaphylactic reaction
•11. Pregnancy, breast feeding or intention to become pregnant
•12. Judged inappropriate

发起方

Itoh Manabu